These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3997314)

  • 1. Pharmacokinetics of nifedipine.
    Pasanisi F; Meredith PA; Reid JL
    Int J Clin Pharmacol Res; 1985; 5(1):63-6. PubMed ID: 3997314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].
    Lutz D; Pabst G; Dahmen W; Molz KH; Jaeger H
    Arzneimittelforschung; 1985; 35(12):1840-2. PubMed ID: 4096741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bioavailability of new nifedipine preparations in man. 2. Bioequivalence of nifedipine in the form of soft gelatin capsules].
    Dahmen W; Pabst G; Molz KH; Lutz D; Jaeger H
    Arzneimittelforschung; 1985; 35(12):1842-4. PubMed ID: 4096742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
    Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
    Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of nicardipine following oral and intravenous administration in man.
    Graham DJ; Dow RJ; Freedman D; Mroszczak E; Ling T
    Postgrad Med J; 1984; 60 Suppl 4():7-10. PubMed ID: 6527979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of nifedipine and prediction of plasma concentration on essential hypertensive patients.
    Kuroda T; Yokoyama T; Umeda T; Ohnishi N; Kuroda K; Inoh T; Inatome T; Yamaguchi A; Asada S
    Kobe J Med Sci; 1985 Jun; 31(3):133-44. PubMed ID: 4046505
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of nifedipine derived from a new retard tablet formulation.
    Avgerinos A; Gorrod JW
    Eur J Drug Metab Pharmacokinet; 1990; 15(4):273-8. PubMed ID: 2088764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of food and posture on the pharmacokinetics of a biphasic release preparation of nifedipine.
    Challenor V; Waller DG; Gruchy BS; Renwick AG; George CF; McMurdo ET; McEwen J
    Br J Clin Pharmacol; 1986 Nov; 22(5):565-70. PubMed ID: 3790403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aiming for steady 24-hour plasma concentrations: a comparison of two calcium antagonist and beta-blocker combinations.
    Eriksson M; Nyberg G; Lidman K; Olofsson B; Bergstrand R
    Blood Press Suppl; 1993; 1():16-21. PubMed ID: 7909705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of conventional and slow release forms of nifedipine in essential hypertensive patients.
    Imai Y; Abe K; Sasaki S; Nihei M; Sekino H; Yoshinaga K
    Tohoku J Exp Med; 1986 Apr; 148(4):421-38. PubMed ID: 3738908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence and metabolism of nitrendipine administered orally to healthy volunteers.
    Kann J; Krol GJ; Raemsch KD; Burkholder DE; Levitt MJ
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S968-73. PubMed ID: 6085386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy.
    Sawada T; Kondo H; Nakashima H; Sako K; Hayashi M
    Int J Pharm; 2004 Aug; 280(1-2):103-11. PubMed ID: 15265551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of oral lidocaine and nifedipine in patients with liver cirrhosis.
    Tonsuwannont W; Praisontarangkul OA; Manorot M; Klangwarnwong D
    J Med Assoc Thai; 1996 May; 79(5):309-19. PubMed ID: 8708523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers.
    Bareggi SR; Gambaro V; Valenti M; Benvenuti C
    Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in nifedipine concentration-effect relationship between capsule and slow release tablet administration.
    Castañeda-Hernández G; Hoyo-Vadillo C; Herrera JE
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):56-60. PubMed ID: 7711994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral slow-release nifedipine in the rapid treatment of severe hypertension in Nigerians.
    Arije A; Omotoso AB; Erasmus RT
    West Afr J Med; 1994; 13(2):116-20. PubMed ID: 7803325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady state kinetics of a fatty alcohol-based slow-release nifedipine for once a day application.
    Woodcock BG; Merz PG; Rietbrock S; Rudolph B; Pfleiderer S
    Arzneimittelforschung; 1993 Jul; 43(7):734-6. PubMed ID: 8369004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.